Samsung Electronics Co. accounted for 28.4 percent of smartphone sales in Russia in the third quarter to edge Chinese rival Huawei Technologies Co. by 2.9 percent for the top spot, according to market researcher Counterpoint Research.
Xiaomi Corp., another Chinese firm came in third with a 22.6 percent share followed by Apple Inc. with a 9.2 percent.
In terms of online smartphone sales, Samsung was third with a 26.3 percent share, trailing Huawei with 27.8 percent and Xiaomi with 27 percent.
Counter Research attributes the decrease in Samsung's market share for online sales to its decision to depend on offline sales after the restoration of normalcy in retail store operations.
Counterpoint Research noted that Samsung Galaxy A51, Samsung Galaxy A31, and Apple iPhone 11 were the top-sellers on online platforms.
Meanwhile, offline platforms have Samsung Galaxy A51, Redmi Note 8T, and Samsung Galaxy A31 as their best sellers.
Third-quarter sales of smartphones in Russia grew 5 percent on-year, with 34 percent purchased online due to the pandemic.


OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Google Secures Pentagon AI Deal for Classified Projects
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 



